iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
iTonic Holdings Ltd, a healthcare solution provider specializing in brachytherapy treatment planning systems, announced that Nasdaq approved their request for a 180-calendar day extension, until October 19, 2026, to comply with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company received notification on April 21, 2026, following the expiration of the initial compliance period on April 20, 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments